Licensed US ProvidersHSA/FSA EligibleHIPAA CompliantFree Discreet ShippingCancel Anytime
READY®
Get Started
Get Started

GLP-1 Users · Ozempic · Wegovy · Mounjaro · DEEP BREATH\u2122 by READY

Ozempic changed
your body.

It may have also changed your desire.

Millions of Americans on semaglutide or tirzepatide experience reduced libido and emotional disconnection as side effects. DEEP BREATH\u2122 is now available in all 50 states.

Free consultation · Takes 2 minutes · No charge until approved

Couple enjoying breakfast together

182

Sexual adverse events reported to FDA FAERS (2024–2025)

Statistically significant p<0.0001

0

Clinically significant interactions identified in available literature

Consult your provider

50

US states where DEEP BREATH™ is available

Licensed clinicians nationwide

The science

Why this happens.

Neurochemical pathways

Couple relaxing together

GLP-1 agonists work by increasing serotonergic activity at the 5-HT2C receptor. That same mechanism suppresses sexual desire — it's the same pathway as SSRI-induced sexual dysfunction. The effect is real. And it's rarely discussed.

Oxytocin operates on entirely different neurochemical pathways — oxytocinergic and dopaminergic. It doesn't compete with your GLP-1 medication. It complements it.

View the full science

DEEP BREATH\u2122

Your plan.

Prescribed alongside your existing GLP-1 therapy. Your provider reviews the full picture.

6 Months

Best value

$129/mo

6 bottles · Priority shipping · Save $420

Get started

Monthly

$199/mo

1 bottle · Cancel anytime after 2 months

Get started

Prescription required. Not FDA-approved. No charge until provider approval. HSA/FSA eligible.

Common questions

GLP-1 users ask.

Start consultation

Free · Takes 2 minutes · No charge until approved

Oxytocin operates on oxytocinergic and dopaminergic pathways, entirely separate from GLP-1 receptor mechanisms. Your DEEP BREATH™ provider will review your complete medication list during the consultation and make the final determination.

We recommend informing your prescribing physician. Your DEEP BREATH™ provider will document all current medications in your consultation intake to ensure a complete clinical picture.

In the Muin et al. 2015 clinical trial, participants reported improvements within the first weeks of use. Individual results vary. Your provider will discuss realistic expectations during your consultation.

DEEP BREATH™ is available in all 50 US states. A licensed clinician in your state will review your consultation and, if appropriate, prescribe DEEP BREATH™ for delivery to your door.